| Immunotherapy comes of age in octagenarian and nonagenarian metastatic melanoma patients G Ben-Betzalel, Y Steinberg-Silman, R Stoff, N Asher, R Shapira-Frommer, ... European Journal of Cancer 108, 61-68, 2019 | 55 | 2019 |
| Correlation of body composition by computerized tomography and metabolic parameters with survival of nivolumab-treated lung cancer patients V Magri, T Gottfried, M Di Segni, D Urban, M Peled, S Daher, R Stoff, J Bar, ... Cancer Management and Research, 8201-8207, 2019 | 46 | 2019 |
| Diagnosis of cytomegalovirus infection during exacerbation of ulcerative colitis A Levin, S Yaari, R Stoff, O Caplan, DG Wolf, E Israeli Digestion 96 (3), 142-148, 2017 | 33 | 2017 |
| Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program O Illini, H Fabikan, A Swalduz, A Vikström, D Krenbek, M Schumacher, ... Therapeutic advances in medical oncology 14, 17588359221103206, 2022 | 21 | 2022 |
| Better late than never: the impact of steroidal treatment on the outcome of melanoma patients treated with immunotherapy N Bar-Hai, G Ben-Betzalel, R Stoff, S Grynberg, J Schachter, ... Cancers 15 (11), 3041, 2023 | 11 | 2023 |
| Real world evidence of Lenvatinib+ anti PD-1 as an advanced line for metastatic melanoma R Stoff, N Asher, S Laks, Y Steinberg, J Schachter, R Shapira-Frommer, ... Frontiers in Oncology 13, 1180988, 2023 | 11 | 2023 |
| Neoadjuvant BRAF-targeted therapy for ameloblastoma of the mandible: an organ preservation approach S Grynberg, M Vered, R Shapira-Frommer, N Asher, G Ben-Betzalel, ... JNCI: Journal of the National Cancer Institute 116 (4), 539-546, 2024 | 10 | 2024 |
| Avelumab for the treatment of locally advanced or metastatic Merkel cell carcinoma—A multicenter real‐world experience in Israel I Averbuch, R Stoff, M Miodovnik, S Fennig, G Bar‐Sela, A Yakobson, ... Cancer Medicine 12 (11), 12065-12070, 2023 | 10 | 2023 |
| Efficacy and toxicity of Ipilimumab-Nivolumab combination therapy in elderly metastatic melanoma patients R Stoff, S Grynberg, N Asher, S Laks, Y Steinberg, J Schachter, ... Frontiers in Oncology 12, 1020058, 2022 | 8 | 2022 |
| Fecal microbiota transplantation as a cancer therapeutic R Stoff, Y Wolf, B Boursi The Cancer Journal 29 (2), 102-108, 2023 | 7 | 2023 |
| Liquid first is “solid” in naïve non-small cell lung cancer patients: Faster turnaround time with high concordance to solid next-generation sequencing O Sehayek, W Kian, A Onn, R Stoff, HG Sorotsky, M Zemel, J Bar, ... Frontiers in Oncology 12, 912801, 2022 | 7 | 2022 |
| Incidence and outcome of neurologic immune-related adverse events associated with immune checkpoint inhibitors in patients with melanoma J Pepys, R Stoff, R Ramon-Gonen, G Ben-Betzalel, S Grynberg, ... Neurology 101 (24), e2472-e2482, 2023 | 6 | 2023 |
| Radiotherapy may augment response to immunotherapy in metastatic uveal melanoma patients S Grynberg, R Stoff, N Asher, R Shapira-Frommer, J Schachter, ... Therapeutic Advances in Medical Oncology 14, 17588359221131521, 2022 | 6 | 2022 |
| Exploring the clinical significance of specific immune-related adverse events in melanoma patients undergoing immune checkpoint inhibitor therapy N Asher, N Bar-Hai, G Ben-Betzalel, R Stoff, S Grynberg, J Schachter, ... Melanoma Research 34 (5), 439-449, 2024 | 2 | 2024 |
| Exploring the clinical significance of specific immune-related adverse events (irAE) in patients with melanoma undergoing immune checkpoint inhibitor (ICI) therapy. N Asher, N Bar-Hai, G Ben-betzalel, R Stoff, S Grynberg, J Schachter, ... Journal of Clinical Oncology 41 (16_suppl), 9566-9566, 2023 | 1 | 2023 |
| EP08. 02-122 Real-world Experience with Capmatinib in MET Exon 14-mutated Non-small Cell Lung Cancer (RECAP) O Illini, H Fabikan, A Swalduz, D Krenbek, A Vikström, M Schumacher, ... Journal of Thoracic Oncology 17 (9), S460, 2022 | 1 | 2022 |
| The increasing role of abdominal metastesectomy for malignant melanoma in the era of modern therapeutics E Mor, S Laks, D Assaf, N Asher, G Ben-Betzalel, S Grynberg, R Stoff, ... Surgical Oncology 44, 101808, 2022 | 1 | 2022 |
| BRAF-targeted therapy for locally advanced ameloblastoma of the mandible: A potential neoadjuvant strategy. S Grynberg, Y Steinberg, N Asher, G Ben-Betzalel, R Stoff, G Markel, ... Journal of Clinical Oncology 40 (16_suppl), 3149-3149, 2022 | 1 | 2022 |
| 526 Removal of soluble tumor necrosis factors receptors 1/2 in patients with metastatic solid tumors using immune apheresis A Tamir, H Harati, N Asher, R Stoff, S Grynberg, R Segal, A Ostrowski, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A556-A556, 2021 | 1 | 2021 |
| Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital setting R Stoff, SN Markovic, RR McWilliams, LA Kottschade, HN Montane, ... Melanoma Research 34 (6), 510-518, 2024 | | 2024 |
